Skip to content
Stop using now Medical device recall · FDA · Published December 9, 2021

Getinge Vaporizer Sevoflurane Filling Risk: Chemical Degradation May Cause Inhalation

Getinge recalls Sevoflurane vaporizer filling part 6886601 due to potential chemical degradation that may cause hydrogen fluoride inhalation or skin exposure. Affected units include specific anesthesia systems with serial numbers listed in the recall notice.

🇺🇸 FDA recall #Z-0468-2022Medical deviceGetinge ›
Take action

Contact the company

Recalling firmGetinge Usa Sales Inc1 Geoffrey Way · Wayne, NJ 07470-2035
✎ GovInfoNow plain-language explainer

Getinge is recalling a specific vaporizer filling part (6886601) used in some anesthesia systems because it may degrade and release hydrogen fluoride, which can cause inhalation or skin exposure. This is a serious hazard that requires immediate action to prevent potential injury. Read more at govinfonow.com/recall/61450-getinge-vaporizer-sevoflurane-filling-risk-chemical-degradation-may-cause-inhalation.

Source Summary by GovInfoNow · govinfonow.com/recall/61450-getinge-vaporizer-sevoflurane-filling-risk-chemical-degradation-may-cause-inhalation · Updated August 19, 2026 · FDA enforcement record: FDA #Z-0468-2022

Cite this page

“Getinge Vaporizer Sevoflurane Filling Risk: Chemical Degradation May Cause Inhalation.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/61450-getinge-vaporizer-sevoflurane-filling-risk-chemical-degradation-may-cause-inhalation. Based on FDA recall #Z-0468-2022 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0468-2022%22&limit=1).

Getinge Usa Sales Inc recalled the Vaporizer Sevoflurane Maquet Filling, Part No. 6886601, due to potential chemical degradation that may result in hydrogen fluoride exposure, according to the FDA on Dec. 9, 2021.

How to tell if you have it

  • Brand: Getinge
  • Product: Vaporizer Sevoflurane Maquet Filling, Part No. 6886601
  • Component of Flow-c Anesthesia System (Part No. 6887700, UPC 07325710009765)
  • Component of Flow-e Anesthesia System (Part No. 6887900, UPC 07325710010457)
  • Component of Flow-i Anesthesia System C20 (Part No. 6888520, UPC 07325710010617)
  • Component of Flow-i Anesthesia System C30 (Part No. 6888530, UPC 07325710010624)
  • Component of Flow-i Anesthesia System C40 (Part No. 6888540, UPC 07325710010631)
  • Component of Flow-i C20 Anesthesia System (Part No. 6677200, UPC 07325710001349)
  • Component of Flow-i C30 Anesthesia System (Part No. 6677300, UPC 07325710001349)
  • Component of Flow-i C40 Anesthesia System (Part No. 6677400, UPC 07325710010631)
  • UDI: 07325710008430
  • Serial Nos.: 15580, 15890, 15924, 16284, 16637, 16837, 16970, 15582, 15891, 15925, 16285, 16638, 16840, 16971, 15721, 15894, 16268, 16345, 16639, 16842, 15722, 15914, 16269, 16352, 16640, 16843, 15725, 15917, 16270, 16354, 16690, 16844, 15726, 15919, 16271, 16632, 16828, 16961, 15728, 15920, 16272, 16633, 16832, 16964, 15729, 15921, 16273, 16634, 16833, 16965, 15731, 15922, 16276, 16635, 16834, 16966, 15732, 15923, 16283, 16636, 16836, 16968
  • Distribution: Worldwide; US (VA, MO)

The hazard

A potential chemical degradation of Sevoflurane by Lewis acids may result in inhalation and/or skin exposure of hydrogen fluoride. The FDA classified the recall as Class I.

Context

GovInfoNow's records show Getinge Usa Sales Inc has 16 other recalls on record since April 1, 2022. Other recent recalls include the Getinge Vaporizer Sevoflurane Recall (Jan. 15, 2025), the Getinge MEERA CL Mobile Operating Table Recall (Oct. 3, 2024), and the Getinge ALPHAMAXX Mobile Operating Table Charger Recall (May 29, 2024). Other recent recalls of similar products include the Draeger Vapor 3000 Anesthetic Vaporizer Recall (Nov. 24, 2025), the Draeger Vapor 2000 Anesthetic Vaporizer Recall (Nov. 24, 2025), and the Medline Medical Kits Recall (Dec. 16, 2025).

How to tell if you have this one

Check if your anesthesia system includes the vaporizer filling part with serial numbers listed: 15580, 15890, 15924, 16284, 16637, 16837, 16970, and other numbers in the recall notice. The part is used in specific anesthesia systems like Flow-c, Flow-e, and Flow-i models.

  • Brand
    Getinge
  • Category
    Medical device
Based on the official FDA remedy

What to do — step by step

  1. Stop Using the Vaporizer Now

    Immediately stop using the recalled vaporizer filling part (part number 6886601) as it may release harmful hydrogen fluoride.

Where it went and when

Where it was distributed

Distributed nationwide and abroad; the notice names 2 states.

Alaska: nationwideAKMaine: nationwideMEVermont: nationwideVTNew Hampshire: nationwideNHWashington: nationwideWAIdaho: nationwideIDMontana: nationwideMTNorth Dakota: nationwideNDMinnesota: nationwideMNIllinois: nationwideILWisconsin: nationwideWIMichigan: nationwideMINew York: nationwideNYRhode Island: nationwideRIMassachusetts: nationwideMAOregon: nationwideORNevada: nationwideNVWyoming: nationwideWYSouth Dakota: nationwideSDIowa: nationwideIAIndiana: nationwideINOhio: nationwideOHPennsylvania: nationwidePANew Jersey: nationwideNJConnecticut: nationwideCTCalifornia: nationwideCAUtah: nationwideUTColorado: nationwideCONebraska: nationwideNEMissouri: named in the noticeMOKentucky: nationwideKYWest Virginia: nationwideWVVirginia: named in the noticeVAMaryland: nationwideMDDelaware: nationwideDEArizona: nationwideAZNew Mexico: nationwideNMKansas: nationwideKSArkansas: nationwideARTennessee: nationwideTNNorth Carolina: nationwideNCSouth Carolina: nationwideSCDistrict of Columbia: nationwideDCOklahoma: nationwideOKLouisiana: nationwideLAMississippi: nationwideMSAlabama: nationwideALGeorgia: nationwideGAHawaii: nationwideHITexas: nationwideTXFlorida: nationwideFL

FDA distribution: “Worldwide distribution - US Nationwide distribution in the states of VA and MO. The countries of Austria, Bahrain, Bolivia, Brazil, Bulgaria, Chile, China, Colombia, Estonia, Iraq, Israel, Italy, Japan, Kenya, Malaysia, Mexico, Morocco,…” States read from FDA’s own wording; “not listed” means the notice does not name it.

Named in the notice: Missouri, Virginia.

Recall timeline

FDA published this recall 41 days after the firm started it.

1. Firm started the recall: Dec 9, 202112. FDA classified it Class I: Jan 10, 202223. Published in FDA’s Enforcement Report: Jan 19, 2022320212022
  1. Firm started the recall
  2. FDA classified it Class I
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-0468-2022 (December 9, 2021) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-0468-2022 to see it in context.
  • Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA